Key result
Higher VE/VCO2 slope on CPET independently predicted non-sustained ventricular tachycardia in hypertrophic cardiomyopathy patients.
Why the study?
Hypertrophic cardiomyopathy carries an elevated risk of ventricular arrhythmias and sudden cardiac death, motivating evaluation of the relationship between cardiopulmonary exercise test parameters and ventricular arrhythmias in these patients.
Do cardiopulmonary exercise test parameters (such as VE/VCO2 slope, COP, and pVO2) predict the risk of ventricular arrhythmias in patients with hypertrophic cardiomyopathy?
Cohort (n=67)
No
Do cardiopulmonary exercise test parameters (such as VE/VCO2 slope, COP, and pVO2) predict the risk of ventricular arrhythmias in patients with hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
VE/VCO2 slope from cardiopulmonary exercise testing independently predicts non-sustained ventricular tachycardia in hypertrophic cardiomyopathy patients, outperforming peak VO2 for arrhythmic risk stratification.
Introduction Hypertrophic cardiomyopathy (HCM) is linked to an elevated risk of ventricular arrhythmias (VA) and sudden cardiac death (SCD). Cardiopulmonary exercise test (CPET) parameters, including peak oxygen consumption (pVO2) and ventilatory efficiency (VE/VCO2 slope), are currently employed to assess functional capacity, prognosis, and arrhythmic risk. Aim To evaluate the relationship/association between CPET parameters and VA in HCM patients. Methods Single-center retrospective study evaluating the associa&on between CPET parameters and VA in HCM pa&ents (pts) who underwent CPET between 2018-2025. Sustained (SVT) or non-sustained ventricular tachycardia (NSVT) was detected via 24-hour holter monitoring, implantable loop recorder or implantable cardioverter-defibrillator (ICD). Results Sixty-seven consecutive HCM pts underwent CPET (66% male, mean age 57±16 years, 19% with obstruc&ve HCM). In a mean follow-up of 69±50 months, SVT occurred in 7%, and NSVT in 42%. Pts with NSTV included more females (50% vs 23%, p=0.024) and had a higher extension of late gadolinium enhancement (LGE) (16% vs 9.6%, p=0.049) compared to pts without VAs during follow-up. Pts with NSVTs showed a higher VE/VCO2 slope (p=0.006), higher cardiorespiratory op&mal point (COP)(p=0.022), and lower maximal heart rate (HR)(p=0.019) compared to patients without VA. In a univariate regression analysis, a higher VE/VCO2 slope (adjusted OR 1.125, p=0.009), and higher CROP (adjusted OR 1.14, p=0.029) were significantly associated with occurrence of NSVT. The prognos&c value of VE/VCO2 slope was confirmed in both submaximal (adjusted OR 1.165, p = 0.041) and maximal (adjusted OR 1.115, p=0.019) exercise testing. The prognostic value of COP was also confirmed for both maximal and submaximal efforts. Maximal HR was significantly associated with NSVTs only in patients with submaximal effort (adjusted OR 0.997, p=0.021). pVO2 did not show a significant association with VAs (p=0.222) nor percent of predicted pVO2 (p=0.117). In a multivariate regression analysis VE/VCO2 slope remained an independent predictor of NSVT even after adjusting for sex, age, genotype, wall thickness, (adjusted OR 1.173, p=0.037), but not for %LGE (p=0.546). This multivariate predictive value was only present during maximal CPET tests, not submaximal (p=0.918). ROC curve analysis showed moderate discriminatory ability for VE/VCO2 slope (AUC=0.696, p=0.002, cutoff 28.9). COP was also significant but with lower accuracy (AUC=0.678, p=0.012, cutoff 24.35). ROC curve for pVO2 demonstrated poor discriminatory ability (AUC=0.321). Conclusion VE/VCO2 slope was an independent prognostic marker for the prediction of NSVT in pa&ents with HCM, showing a higher predictive value than pVO2 or COP, highlighting the role of CPET as an additional stratification tool for ventricular arrhythmic risk assessment in HCM patients.
No takes yet. Share an insight, caveat, or question.
Pinheiro et al. (2026) conducted a cohort in Hypertrophic cardiomyopathy (HCM) (n=67). Cardiopulmonary exercise test (CPET) parameters (VE/VCO2 slope, COP, pVO2) vs. Patients without ventricular arrhythmias during follow-up was evaluated on Non-sustained ventricular tachycardia (NSVT) and sustained ventricular tachycardia (SVT) (OR 1.173, p=0.037). Higher VE/VCO2 slope on CPET independently predicted non-sustained ventricular tachycardia in hypertrophic cardiomyopathy patients.
Synapse has enriched 10 related papers. Consider them for comparative context: